CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 ALX Oncology Holdings Inc. - ALXO CFD

4.63
4.14%
0.05
最低: 4.56
最高: 4.84
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.05
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 4.83
开盘价* 4.78
1 年变化* -74.08%
日范围* 4.56 - 4.84
52 周范围 4.52-19.85
平均交易量（10 天） 429.94K
平均交易量（3 个月) 4.73M
市值 195.63M
市盈率 -100.00K
流通股 40.86M
收入 N/A
EPS -3.03
股息（收益率 %） N/A
贝塔 -100.00K
下一个财报发布日期 May 8, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 23, 2023 4.83 0.29 6.39% 4.54 4.87 4.54
Mar 22, 2023 4.78 -0.04 -0.83% 4.82 4.95 4.63
Mar 21, 2023 4.79 0.09 1.91% 4.70 5.02 4.68
Mar 20, 2023 4.60 -0.16 -3.36% 4.76 4.78 4.49
Mar 17, 2023 4.76 -0.15 -3.05% 4.91 4.95 4.63
Mar 16, 2023 4.98 -0.08 -1.58% 5.06 5.13 4.92
Mar 15, 2023 5.17 0.09 1.77% 5.08 5.38 4.67
Mar 14, 2023 5.23 -0.49 -8.57% 5.72 5.74 5.07
Mar 13, 2023 5.60 0.42 8.11% 5.18 5.90 5.18
Mar 10, 2023 5.36 -0.33 -5.80% 5.69 5.73 5.02
Mar 9, 2023 5.84 -0.27 -4.42% 6.11 6.19 5.60
Mar 8, 2023 6.21 -0.16 -2.51% 6.37 6.39 6.11
Mar 7, 2023 6.37 0.07 1.11% 6.30 6.54 6.29
Mar 6, 2023 6.44 -0.04 -0.62% 6.48 6.48 6.20
Mar 3, 2023 6.50 0.19 3.01% 6.31 6.67 6.31
Mar 2, 2023 6.45 0.11 1.74% 6.34 6.47 6.23
Mar 1, 2023 6.48 0.04 0.62% 6.44 6.60 6.43
Feb 28, 2023 6.59 0.16 2.49% 6.43 6.66 6.43
Feb 27, 2023 6.63 0.15 2.31% 6.48 6.74 6.48
Feb 24, 2023 6.54 -0.30 -4.39% 6.84 6.84 6.39

ALX Oncology Holdings Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 0 1.182 4.796 2.067
收入 0 1.182 4.796 2.067
收入成本，共计 1.075 4.36 1.88
毛利 0.107 0.436 0.187
总营业费用 83.555 45.466 23.979 15.751
销售/一般/行政费用，总计 23.385 14.809 3.313 2.601
研究与开发 60.17 28.961 16.306 11.27
营业收入 -83.555 -44.284 -19.183 -13.684
利息收入（费用），非经营净值 -0.013 -0.811 -0.021 0
其他，净值 0.084 -0.404 -0.005 -0.002
税前净收入 -83.484 -45.499 -19.209 -13.686
税后净收入 -83.463 -45.74 -19.243 -13.731
未计算非常项目前的净收益 -83.463 -45.74 -19.243 -13.731
净收入 -83.463 -45.74 -19.243 -13.731
Total Adjustments to Net Income 0 -5.202 -4.028 -3.671
普通股股东可获收益 (不含非经常性项目) -83.463 -50.942 -23.271 -17.402
普通股股东可获收益 (含非經常性項目) -83.463 -50.942 -23.271 -17.402
摊薄净收入 -83.463 -50.942 -23.271 -17.402
摊薄后加权平均股 40.308 18.4853 34.7116 34.7116
扣除特别项目的每股摊薄盈利 -2.07063 -2.7558 -0.67041 -0.50133
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -2.07063 -2.73397 -0.67041 -0.50133
异常费用（收入） 0 0.621
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
收入 0 0 0 0
总营业费用 24.747 28.472 24.576 16.299 14.208
销售/一般/行政费用，总计 7.674 7.578 6.362 5.086 4.359
研究与开发 17.073 20.894 18.214 11.213 9.849
营业收入 -24.747 -28.472 -24.576 -16.299 -14.208
利息收入（费用），非经营净值 0.225 -0.003 -0.004 -0.003 -0.003
其他，净值 -0.011 0.016 0.014 0.028 0.026
税前净收入 -24.533 -28.459 -24.566 -16.274 -14.185
税后净收入 -24.533 -28.438 -24.566 -16.274 -14.185
未计算非常项目前的净收益 -24.533 -28.438 -24.566 -16.274 -14.185
净收入 -24.533 -28.438 -24.566 -16.274 -14.185
Total Adjustments to Net Income 0 0 0 0
普通股股东可获收益 (不含非经常性项目) -24.533 -28.438 -24.566 -16.274 -14.185
普通股股东可获收益 (含非經常性項目) -24.533 -28.438 -24.566 -16.274 -14.185
摊薄净收入 -24.533 -28.438 -24.566 -16.274 -14.185
摊薄后加权平均股 40.6163 40.5297 40.3962 40.2471 40.0554
扣除特别项目的每股摊薄盈利 -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
收入成本，共计 0 0
毛利 0 0
异常费用（收入） 0
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 367.019 435.992 9.809 10.208
现金和短期投资 363.667 434.219 9.017 8.262
Cash 434.219 9.017 8.262
应收账款总额，净额 0 0.536 0.932
Accounts Receivable - Trade, Net 0 0.536 0.932
Prepaid Expenses 3.352 1.773 0.256 1.014
Total Assets 380.183 436.054 10.676 11.164
Property/Plant/Equipment, Total - Net 3.397 0.052 0.86 0.956
Property/Plant/Equipment, Total - Gross 3.46 0.077 2.309 1.976
Accumulated Depreciation, Total -0.063 -0.025 -1.449 -1.02
Other Long Term Assets, Total 9.767 0.01 0.007 0
Total Current Liabilities 15.295 6.204 4.984 1.873
Accounts Payable 3.764 0.004 3.748 0.697
Accrued Expenses 11.102 6.049 1.046 0.905
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.151 0.19 0.271
Total Liabilities 17.134 6.209 10.952 2.009
Total Long Term Debt 0.28 0 5.421 0
Long Term Debt 5.421 0
Other Liabilities, Total 1.559 0.005 0.547 0.136
Total Equity 363.049 429.845 -0.276 9.155
Preferred Stock - Non Redeemable, Net 70.363 60.933
Common Stock 0.041 0.04 0.021 0.021
Additional Paid-In Capital 564.993 548.327 2.122 1.74
Retained Earnings (Accumulated Deficit) -201.985 -118.522 -72.782 -53.539
Total Liabilities & Shareholders’ Equity 380.183 436.054 10.676 11.164
Total Common Shares Outstanding 40.5871 39.8445 34.7116 34.7116
Redeemable Preferred Stock 0
现金等价物 363.667
Current Port. of LT Debt/Capital Leases 0.429
Capital Lease Obligations 0.28
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 321.525 367.019 388.963 412.277 432.327
现金和短期投资 316.596 363.667 385.149 409.964 429.855
现金等价物 159.086 363.667 385.149 409.964 429.855
Prepaid Expenses 4.929 3.352 3.814 2.313 2.472
Total Assets 363.676 380.183 399.728 421.289 432.91
Property/Plant/Equipment, Total - Net 6.967 3.397 3.362 0.167 0.047
Property/Plant/Equipment, Total - Gross 7.088 3.46 3.401 0.2 0.077
Accumulated Depreciation, Total -0.121 -0.063 -0.039 -0.033 -0.03
Other Long Term Assets, Total 10.075 9.767 7.403 8.845 0.536
Total Current Liabilities 15.308 15.295 12.488 13.979 14.129
Accounts Payable 5.133 3.764 3.683 5.806 7.35
Accrued Expenses 9.746 11.102 8.376 7.744 2.735
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.429 0.429 0.429 0.429 0.095
Other Current Liabilities, Total 3.949
Total Liabilities 20.08 17.134 14.556 16.275 14.426
Total Long Term Debt 0.175 0.28 0.385 0.489 0.131
Capital Lease Obligations 0.175 0.28 0.385 0.489 0.131
Other Liabilities, Total 4.597 1.559 1.683 1.807 0.166
Total Equity 343.596 363.049 385.172 405.014 418.484
Redeemable Preferred Stock 0
Common Stock 0.041 0.041 0.04 0.04 0.04
Additional Paid-In Capital 570.679 564.993 558.679 553.955 551.151
Retained Earnings (Accumulated Deficit) -226.518 -201.985 -173.547 -148.981 -132.707
Total Liabilities & Shareholders’ Equity 363.676 380.183 399.728 421.289 432.91
Total Common Shares Outstanding 40.6566 40.5871 40.4863 40.3253 40.2086
短期投资 157.51
Long Term Investments 25.109
Other Equity, Total -0.606
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -83.463 -45.74 -19.243 -13.731
经营活动产生的现金 -68.101 -38.289 -14.249 -13.19
经营活动产生的现金 0.051 0.202 0.429 0.431
非现金物品 19.338 7.002 0.308 0.269
营运资金的变化 -4.027 0.247 4.257 -0.159
投资活动产生的现金 -4.923 0.61 -0.353 -0.653
资本支出 -4.923 -0.031 -0.353 -0.653
融资活动产生的现金 2.472 462.881 15.357 0.001
股票的发行（报废），净额 2.753 473.235 9.44 0.001
债务的发行（退还），净额 -0.281 0 5.917 0
现金净变化 -70.552 425.202 0.755 -13.842
Cash Taxes Paid 0.274 0.047
已付现金利息 0.011 0.427
其他投资现金流量项目，总计 0.641
融资现金流项目 -10.354
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -24.533 -83.463 -55.025 -30.459 -14.185
Cash From Operating Activities -20.674 -68.101 -50.613 -25.757 -5.135
Cash From Operating Activities 0.058 0.051 0.017 0.011 0.005
Non-Cash Items 5.926 19.338 8.688 4.241 1.858
Cash Interest Paid 0 0.011 0.007 0.003 0
Changes in Working Capital -2.125 -4.027 -4.293 0.45 7.187
Cash From Investing Activities -183.921 -4.923 -0.405 -0.007 -0.007
Capital Expenditures -0.589 -4.923 -0.405 -0.007 -0.007
Cash From Financing Activities 0.08 2.472 1.948 1.509 0.778
Issuance (Retirement) of Stock, Net 0.185 2.753 2.125 1.582 0.778
Net Change in Cash -204.515 -70.552 -49.07 -24.255 -4.364
Cash Taxes Paid 0 0.274 0.274 0.274
Financing Cash Flow Items 0 0
Issuance (Retirement) of Debt, Net -0.105 -0.281 -0.177 -0.073
Other Investing Cash Flow Items, Total -183.332 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
VenBio Partners LLC Private Equity 23.8003 9699925 0 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 14.9987 6112789 1482504 2022-12-31 LOW
Lightstone Ventures, L.P. Investment Advisor 11.1076 4526963 -194027 2022-03-31 LOW
Vivo Capital, LLC Venture Capital 10.3546 4220048 0 2022-12-31 MED
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 7.0445 2871000 0 2022-12-31 LOW
Logos Global Management LLC Investment Advisor 5.7651 2349600 -621752 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.7051 1510050 40991 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.4941 1424043 14289 2022-12-31 LOW
Eventide Asset Management, LLC Investment Advisor 2.2132 902000 0 2022-12-31 MED
Cormorant Asset Management, LP Hedge Fund 1.5018 612079 -100000 2022-12-31 MED
Redmile Group, LLC Investment Advisor/Hedge Fund 1.4905 607470 -144627 2022-12-31 LOW
Pons (Jaume) Individual Investor 1.3244 539746 -3232 2022-12-29 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.2268 500000 0 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.171 477236 90049 2022-12-31 MED
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 1.1386 464029 -685 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0117 412309 18988 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9656 393550 8987 2022-12-31 LOW
DWS Investments UK Limited Investment Advisor 0.84 342355 142 2022-12-31 MED
Pier Capital, LLC Investment Advisor 0.667 271848 -769 2022-12-31 MED
Randolph (Sophia) Individual Investor 0.6631 270253 44857 2022-12-29 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

ALX Oncology Holdings Inc. Company profile

关于 ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.是一家处于临床阶段的免疫肿瘤学公司。 公司专注于通过开发阻断分化簇47（CD47）检查点途径和连接先天和适应性免疫系统的疗法，使患者能够对抗癌症。 公司正在开发一种检查点抑制剂，其设计对CD47有亲和力，并避免其他CD47阻断方法固有的血液学毒性造成的限制。 其主要候选产品ALX148是一种CD47阻断治疗剂。 ALX148是一种融合蛋白，结合了CD47结合域和其失活的可结晶片段（Fc）域。 ALX148的CD47结合域是信号调节蛋白α（SIRPa）的亲和力增强的细胞外域，该蛋白是骨髓细胞上发现的CD47的天然受体。 它的项目主要是针对CD47的各种肿瘤适应症。

Industry: Bio Therapeutic Drugs

323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

BTC/USD

27,463.80 Price
-3.200% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

12,798.80 Price
+0.420% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 3.0

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易